Which weight loss injections are safest, and what does that actually mean?

The biggest myth: that a lower price means a safer option

Many people searching for the "safest" injection are really asking: which one can I trust, and where do I get it without being burned? That's a reasonable place to start. The uncomfortable truth is that the gravest risks documented in the UK so far have come not from the medicines themselves but from counterfeit products reaching people through unregulated channels. The MHRA has made large seizures of fake pens (some containing insulin rather than the labelled active ingredient) and in October 2025 raided the first illicit UK site producing counterfeit tirzepatide pens. Fake sellers often don't require a clinical assessment before dispatching. That's the red flag, not the medicine. You can check whether any online pharmacy is properly registered using the GPhC's public register, and it takes about thirty seconds.

The licensed injections (Mounjaro and Wegovy) went through years of clinical trials before reaching UK patients. Thousands of adults participated in the SURMOUNT programme for tirzepatide and the STEP programme for semaglutide, with safety tracked at every stage. That body of evidence is what the MHRA reviewed before granting a UK licence. If you want to understand more about whether the weight loss injection is safe, including how the evidence stacks up on effectiveness alongside safety, the comparison of the most effective weight loss injections goes deeper into the trial numbers.

What side effects actually look like, and the ones that need urgent attention

Nausea is the side effect people hear about most, and it's real. Vomiting, loose stools, constipation, indigestion, and fatigue are all part of the documented profile for both tirzepatide and semaglutide, as detailed on the NHS tirzepatide medicines page. These effects tend to be most noticeable after the first injection or after a dose increase, and for most people they settle within a couple of weeks. Keeping well hydrated and eating smaller portions can help.

A small number of people experience more serious reactions. In January 2026, the MHRA issued a Drug Safety Update specifically about acute pancreatitis associated with GLP-1 medicines. The symptom pattern to know: severe stomach pain that comes on suddenly, persists, and may spread toward the back, sometimes with vomiting. This needs same-day emergency assessment. It's rare, but it's serious enough that both prescribers and patients should be aware of it before starting treatment. Gallbladder problems, signs of a severe allergic reaction (swelling, breathing difficulty, rapid heartbeat), and marked dehydration from prolonged vomiting or diarrhoea also warrant prompt contact with a clinician or, depending on severity, A&E. A broader look at documented risks is covered in the safety overview for weight loss injections.

One thing our prescribers hear regularly: people feel reassured once they know what to expect and what to watch for. We understand that starting an injectable medicine can feel daunting, particularly if you've read a lot of conflicting things online. That's normal. The consultation exists precisely to work through that.

Who these injections are and aren't suitable for

Licensed eligibility for both medicines covers adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnoea. Lower BMI thresholds can apply for some ethnic backgrounds under UK clinical guidance. But BMI alone doesn't determine suitability, a prescriber considers your full medical picture, current medicines, and medical history. You can explore the full eligibility criteria in detail on the weight loss injections page.

There are clear groups for whom these injections are not appropriate. They are not licensed for use during pregnancy, while breastfeeding, or when actively trying to conceive. They are not licensed for anyone under 18. People with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2, or a history of pancreatitis, need to discuss this with a prescriber before any treatment is considered. Tirzepatide specifically requires that women using oral contraceptive pills add a non-oral method for the first four weeks of treatment and for four weeks after any dose increase, because the medicine can reduce how much of the pill is absorbed, a detail the NHS England weight-management injections guidance covers clearly. If you're unsure where you stand, the guide on how to get weight loss injections walks through the clinical assessment process.

What happens when something goes wrong, and how to report it

Knowing when to get medical help isn't a sign that the treatment is failing; it's part of using any medicine responsibly. Contact your prescriber or GP the same day for: persistent vomiting or diarrhoea lasting more than 24 hours, signs of dehydration (dark urine, dizziness, no urination), or unexpected changes in mood or thoughts of self-harm. Call 999 or go to A&E for: severe persistent abdominal pain radiating to the back, a serious allergic reaction, or chest pain. Do not wait and see with any of those.

If you experience a side effect you weren't expecting (whether or not it's listed in the Patient Information Leaflet) you can report it yourself through the MHRA's Yellow Card scheme. The same system accepts reports about suspect products or sellers if you have concerns about what you've received. There's also a dedicated section in the nume FAQs covering what to do if you have concerns mid-treatment, and our clinical team is available seven days a week for aftercare. There's a separate, detailed look at one specific concern (the question about injections and vision changes) covered on the weight loss injections and blindness page if that's something you've seen raised.

If you'd like to discuss whether either injection is suitable for your own circumstances, our prescribers go through the safety profile with you as a routine part of the free consultation. Check your eligibility to get started.